MAXITROL OPH OINT Rx
Generic Name and Formulations:
Neomycin 3.5mg, polymyxin B sulfate 10000Units/g, dexamethasone 0.1%.
Alcon Laboratories, Inc.
Indications for MAXITROL OPH OINT:
Ocular inflammation associated with infection.
Small amount of ointment 3–4 times daily. Ointment may be used adjunctively with drops at bedtime. Then prolong dosing interval as condition improves; max 8g per therapeutic course.
Fungal, viral, or mycobacterial infections of the cornea and conjunctiva. Hypersensitivity to corticosteroids.
Not for injection. Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure in prolonged use. Aminoglycoside cross-sensitivity; discontinue if hypersensitivity develops. May mask signs of acute purulent or parasitic infection. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Antibiotics + steroid.
Allergic sensitization, increased intraocular pressure, cataracts, corneal perforation, optic nerve damage, visual defects, delayed wound healing, bleb formation, allergic dermatitis.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL